Three-Year Follow-up of the Ascend Trial: Acalabrutinib Vs Rituximab Plus Idelalisib or Bendamustine in Relapsed/Refractory Chronic Lymphocytic Leukemia

  • Jurczak, Wojciech; 
  • Pluta, Andrzej; 
  • Wach, Malgorzata; 
  • Lysak, Daniel; 
  • Kozak, Tomas; 
  • ... Lee, Jae Hoon; 
  • 외 12명
Citations

WEB OF SCIENCE

11
제목
Three-Year Follow-up of the Ascend Trial: Acalabrutinib Vs Rituximab Plus Idelalisib or Bendamustine in Relapsed/Refractory Chronic Lymphocytic Leukemia
저자
Jurczak, Wojciech; Pluta, Andrzej; Wach, Malgorzata; Lysak, Daniel; Kozak, Tomas; Simkovic, Martin; Kriachok, Iryna; Illes, Arpad; de la Serna, Javier; Dolan, Sean; Campbell, Philip; Musuraca, Gerardo; Jacob, Abraham; Avery, Eric J.; Lee, Jae Hoon; Wang, Min Hui; Yu, Ting; Ghia, Paolo
DOI
10.1182/blood-2021-146570
발행일
2021-11
유형
Meeting Abstract
저널명
Blood
권
138